Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (61-70 of 430) with videos related to

Pageof 43
Sort By:
Cancer Discovery|May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremesAna Aparicio, Christopher J Logothetis, Sankar N Maity
Functional Neurology|April 1, 1991
Clinical observations in early and late onset Parkinson's diseaseS Bostantjopoulou, J Logothetis, Z Katsarou, et al.
Seminars in Oncology|June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancerPaul Mathew, Isaiah J Fidler, Christopher J Logothetis
The Journal of Computed Tomography|October 1, 1988
Clinical and radiologic staging of locally advanced and inoperable bladder carcinomaA Shirkhoda, F H Dexeus, C J Logothetis
Urology|September 1, 1985
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-CC J Logothetis, M L Samuels, S Ogden
Seminars in Oncology|November 14, 2001
Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studiesJ A Merritt, J A Roth, C J Logothetis
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancerChristopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Cancer|December 11, 1999
Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatmentI E McCutcheon, D Y Eng, C J Logothetis
The Journal of Urology|May 1, 1993
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cellsN M Hoosein, C J Logothetis, L W Chung
Pageof 43

Showing results (61-70 of 430) with videos related to

Sort By:
Pageof 43
Cancer Discovery|May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremesAna Aparicio, Christopher J Logothetis, Sankar N Maity
Functional Neurology|April 1, 1991
Clinical observations in early and late onset Parkinson's diseaseS Bostantjopoulou, J Logothetis, Z Katsarou, et al.
Seminars in Oncology|June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancerPaul Mathew, Isaiah J Fidler, Christopher J Logothetis
The Journal of Computed Tomography|October 1, 1988
Clinical and radiologic staging of locally advanced and inoperable bladder carcinomaA Shirkhoda, F H Dexeus, C J Logothetis
Urology|September 1, 1985
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-CC J Logothetis, M L Samuels, S Ogden
Seminars in Oncology|November 14, 2001
Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studiesJ A Merritt, J A Roth, C J Logothetis
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancerChristopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Cancer|December 11, 1999
Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatmentI E McCutcheon, D Y Eng, C J Logothetis
The Journal of Urology|May 1, 1993
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cellsN M Hoosein, C J Logothetis, L W Chung
Pageof 43